Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-30 4:05 pm Purchase | 2026-10-27 | 13G | ACTUATE THERAPEUTICS INC ACTU | Hexstone Capital LLC | 4,225,352 7.700% | 4,225,352 (New Position) | Filing History |
| 2026-04-22 3:24 pm Purchase | 2026-03-31 | 13G | ACTUATE THERAPEUTICS INC ACTU | Voss Value Master Fund, LP | 1,814,263 7.700% | 586,507 (+47.77%) | Filing History |
| 2025-12-17 12:25 pm Purchase | 2025-12-15 | 13G | ACTUATE THERAPEUTICS INC ACTU | Voss Value Master Fund, LP | 1,227,756 5.300% | 1,227,756 (New Position) | Filing History |
| 2025-06-30 12:08 pm Purchase | 2025-06-27 | 13D | ACTUATE THERAPEUTICS INC ACTU | BIOS Fund I LP | 10,267,232 49.800% | 157,856 (+1.56%) | Filing History |
| 2025-05-27 4:15 pm Sale | 2025-05-22 | 13D | ACTUATE THERAPEUTICS INC ACTU | BIOS Fund I LP | 10,109,376 52.400% | -16,112 (-0.16%) | Filing History |
| 2024-08-19 8:59 pm Purchase | 2024-08-14 | 13D | ACTUATE THERAPEUTICS INC ACTU | BIOS Fund I LP | 10,125,488 52.800% | 10,125,488 (New Position) | Filing History |